Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

A research team at Zhejiang University in China have found that two drugs, Abidol and Darunavir, may help treat patients infected with the new coronavirus, reported Changjiang Daily.

Preliminary in-vitro testing showed the drugs to be effective in blocking the virus.

The team is led by Zhejiang University professor Li Lanjuan, who said that the currently used anti-HIV drug Kelizhi does not exhibit adequate effectiveness and has side effects.

Lanjuan calls for the addition of the two new drugs in China National Health Commission’s programme for the treatment of pneumonia caused by the new coronavirus.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Chen Zuobing, a researcher from the team, noted that Abidol and Darunavir were used to treat patients infected by the virus in Zhejiang Province.

Last month, Chinese researchers have selected to test 30 drug candidates for potential therapeutic effects against the Wuhan coronavirus.

The selected candidates include 12 HIV medicines, two respiratory syncytial virus drugs, a schizophrenia medication and an immunosuppressant, along with some traditional Chinese medicines.

The death toll from coronavirus has reached 492, of which 490 are in mainland China, as of 4 February. The number of coronavirus infected cases has surged to nearly 24,527 worldwide. In mainland China, the confirmed cases stand at 24,324, with 3,887 new cases reported.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now